EG ·
NANAZOXID 100MG5ML SUSP. 60ML
NANAZOXID 100MG5ML SUSP. 60ML
Composition
These source-reported data require scientific review and are not treatment advice.
NITAZOXANIDE
· AMOUNT_PER_UNIT
Registration
Packages and prices
NANAZOXID 100MG5 ML SUSPENSION. 60 ML
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| Nanazoxide 100MG 60ml susp | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| EGYGASTREAZ 50 ML SUSP | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| NIT CLEAN 100MG/5ML SUSP. 60ML | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| CRYPTOSEPT 500 MG 12 TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form, route | — EGP |
| XEROVIRINC 500 MG 18 TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form, route | — EGP |
| PROTOSTOP 500 MG 6 TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form, route | — EGP |
| ANTIDIAZOX 500 MG 12 TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form, route | — EGP |
| parazoxanide 500 mg 18caps | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| EGYGASTREAZ 500 MG 10CAP | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| CRYPTONAZ 100 MG / 5 ML 60 ML SUSP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| NITAZODE 100MG/5ML 60ML SUSP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| NANAZOXID 500MG 18 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |